CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

NUVAXOVID

RegulatoryapprovedNUVAXOVIDPositive
AI Analysis

Summary

NUVAXOVID has been approved for active immunization against COVID-19 in individuals aged 12 years and older. The vaccine is indicated for preventing coronavirus disease 2019 caused by SARS-CoV-2.

Outcome Details

NUVAXOVID approved for use in individuals 65 years of age and older, and 12 years through 64 years of age

Importance:6/10
Sentiment:
0.50
vaccineCOVID-19regulatory approvalimmunization
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 27, 2026 5:56 PM

Read Original